Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

nordic group b.v., holandsko - anagrelid - 44 - cytostatica

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

nordic group b.v., holandsko - anagrelid - 44 - cytostatica

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

nordic group b.v., holandsko - anagrelid - 44 - cytostatica

Európska únia - slovenčina - EMA (European Medicines Agency)

nordic group b.v. - tegafur, gimeracil, oteracil - neoplazmy žalúdka - antineoplastické činidlá - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

nordicneurolab as mollendalsveien 1 5009 bergen nórsko -

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

nordicneurolab as mollendalsveien 1 5009 bergen nórsko -

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

nordic pharma, s.r.o., Česká republika - mitomycín - 44 - cytostatica

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

nordic pharma, s.r.o., Česká republika - sinekatechíny - 46 - dermatologica

Európska únia - slovenčina - EMA (European Medicines Agency)

janssen-cilag international n.v.    - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - hemorrhagic fever, ebola - vakcíny - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.

Európska únia - slovenčina - EMA (European Medicines Agency)

nordic group b.v. - metotrexát - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - antineoplastické činidlá - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.